Sort
39,280 grants matching “leukemia”
Targeting Acid Ceramidase in AML
$317,668Thomas P Loughran · Pennsylvania State Univ Hershey Med Ctr · P01 · FY2014 · CA
The Role of the APC Tumor Suppressor Gene in Hematopoiesis and Leukemogenesis
$317,658Zhijian Qian · University Of Chicago · R01 · FY2010 · CA
New Bifunctional Ligands for Radioimmunotherapy
$317,654Hyun-Soon Chong · Illinois Institute Of Technology · R01 · FY2015 · CA
New Bifunctional Ligands for Radioimmunotherapy
$317,654Hyun-Soon Chong · Illinois Institute Of Technology · R01 · FY2017 · CA
New Bifunctional Ligands for Radioimmunotherapy
$317,654Hyun-Soon Chong · Illinois Institute Of Technology · R01 · FY2016 · CA
Regulation of Nuclear Signaling Pathways by the Adenovirus E4 ORF3 Protein
$317,648Patrick Hearing · State University New York Stony Brook · R01 · FY2011 · CA
Project 1: HDAC inhibition and GVHD
$317,617Pavan Reddy · Icahn School Of Medicine At Mount Sinai · P01 · FY2019 · CA
Mechanisms and Prevention of Etoposide-Induced Leukemia
$317,600Jack C. Yalowich · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · CA
Control Mechanisms of Human Voltage Gated Proton Channels, hHv1
$317,598Thomas E Decoursey · Rush University Medical Center · R35 · FY2018 · GM
Development of mechanism-based ovarian reserve protecting adjuvant therapies against gonadotoxic therapeutic agents
$317,581So-Youn Kim · University Of Nebraska Medical Center · R01 · FY2022 · HD
Development of mechanism-based ovarian reserve protecting adjuvant therapies against gonadotoxic therapeutic agents
$317,581So-Youn Kim · University Of Nebraska Medical Center · R01 · FY2023 · HD
Development of mechanism-based ovarian reserve protecting adjuvant therapies against gonadotoxic therapeutic agents
$317,581So-Youn Kim · University Of Nebraska Medical Center · R01 · FY2021 · HD
Crenolanib and ponatinib for the treatment of FLT3 mutant AML
$317,512Neil P Shah · University Of California, San Francisco · R01 · FY2014 · CA
Infectious origins of childhood leukemia
$317,512Markus Mãschen · University Of California, San Francisco · R01 · FY2014 · CA
Cytokines Convert Epithelial Precursors to Nephrons
$317,509Jonathan M. Barasch · Columbia University Health Sciences · R01 · FY2008 · DK
In vivo MR Evaluation of Cell Therapy for Stroke
$317,506Quan Jiang · Henry Ford Health System · R01 · FY2007 · NS
Improved therapeutic approaches for hematological disorder treated with tyrosine
$317,475Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2015 · CA
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
$317,475Ya-Huei Kuo · Beckman Research Institute/City Of Hope · R01 · FY2016 · CA
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
$317,475Ya-Huei Kuo · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
Targeting p300 and lysine acetylation in AML
$317,475Stephen David Nimer · University Of Miami School Of Medicine · R01 · FY2012 · CA
Gadd45 stress sensors in leukemia
$317,475Dan A Liebermann · Temple Univ Of The Commonwealth · R01 · FY2015 · CA
Improved therapeutic approaches for hematological disorder treated with tyrosine
$317,475Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · CA
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
$317,475Ya-Huei Kuo · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
$317,475Qishen Pang · Cincinnati Childrens Hosp Med Ctr · R01 · FY2012 · CA
Regulators of Cancer-Specific DNA Hypermethylation.
$317,475Jean-Pierre J Issa · Temple Univ Of The Commonwealth · R01 · FY2015 · CA